Literature DB >> 12225503

In vivo drug resistance of falciparum malaria in mining areas of Venezuela.

A Aché1, M Escorihuela, E Vivas, E Páez, L Miranda, A Matos, W Pérez, O Díaz, E Izarra.   

Abstract

The Lot Quality Assurance Double-Sampling Plan (LQADSP) technique was used in three areas, Maripa, Kilómetro 88 and Ikabaru, to assess the efficacy of antimalarials used routinely by the Venezuelan Malaria Programme. The use of chloroquine (25 mg/kg), chloroquine (40 mg/kg) and the combination of sulfadoxine (500 mg) and pyrimethamine (25 mg) registered treatment failures above the threshold level of 25% in Maripa and Kilómertro 88. In Ikabaru the use of chloroquine (40 mg/kg) did not surpass that quality level and could possibly be less than 10%. Quinine (30 mg/kg) was totally effective in curing patients in all three areas. The use of this technique seems adequate for rapid field evaluations and in this case for providing appropriate information to assist this health programme. However, whilst being an ideal technique for surveying areas in which considerable variation may exist among lots and particularly for Plasmodium falciparum infections in these areas, repeated surveys should be carried out in the same areas over time to monitor changes in the susceptibility of this parasite to first-, second- and third-line drugs. In that way, national drug policies can be modified adequately.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225503     DOI: 10.1046/j.1365-3156.2002.00936.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

Review 1.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

2.  Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.

Authors:  Frederick N Baliraine; Samuel L Nsobya; Jane Achan; James K Tibenderana; Ambrose O Talisuna; Bryan Greenhouse; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.

Authors:  John Okombo; Steven M Kiara; Josea Rono; Leah Mwai; Lewa Pole; Eric Ohuma; Steffen Borrmann; Lynette Isabella Ochola; Alexis Nzila
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

4.  Efficacy of chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in Honduras.

Authors:  Rosa Elena Mejia Torres; Engels Ilich Banegas; Meisy Mendoza; Cesar Diaz; Sandra Tamara Mancero Bucheli; Gustavo A Fontecha; Md Tauqeer Alam; Ira Goldman; Venkatachalam Udhayakumar; Jose Orlinder Nicolas Zambrano
Journal:  Am J Trop Med Hyg       Date:  2013-03-04       Impact factor: 2.345

5.  Implementation of a novel malaria management strategy based on self-testing and self-treatment in remote areas in the Amazon (Malakit): confronting a-priori assumptions with reality.

Authors:  Muriel Suzanne Galindo; Yann Lambert; Louise Mutricy; Laure Garancher; Jane Bordalo Miller; José Hermenegildo Gomes; Alice Sanna; Cassio Peterka; Hedley Cairo; Helene Hiwat; Antoine Adenis; Mathieu Nacher; Martha Cecilia Suárez-Mutis; Stephen Vreden; Maylis Douine
Journal:  BMC Public Health       Date:  2022-04-15       Impact factor: 4.135

6.  Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.

Authors:  Jane Achan; James K Tibenderana; Daniel Kyabayinze; Fred Wabwire Mangen; Moses R Kamya; Grant Dorsey; Umberto D'Alessandro; Philip J Rosenthal; Ambrose O Talisuna
Journal:  BMJ       Date:  2009-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.